{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:58:12Z","timestamp":1791413892606,"version":"4.3.3"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ygyno.2020.11.003","type":"journal-article","created":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T01:28:42Z","timestamp":1605922122000},"page":"457-463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Embedding a genetic counselor into oncology clinics improves testing rates and timeliness for women with ovarian cancer"],"prefix":"10.1016","volume":"160","author":[{"given":"Huma Q.","family":"Rana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Kipnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Hehir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Cronin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Jaung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha M.","family":"Stokes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Fekrmandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Vatnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula A.","family":"Matulonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy E.","family":"Garber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexi A.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.ygyno.2020.11.003_bb0005","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","article-title":"Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial","volume":"305","author":"Buys","year":"2011","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ygyno.2020.11.003_bb0010","first-page":"5","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2020.11.003_bb0015","doi-asserted-by":"crossref","first-page":"341723","DOI":"10.1155\/2015\/341723","article-title":"Hereditary ovarian cancer: not only BRCA 1 and 2 genes","volume":"2015","author":"Toss","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"44","key":"10.1016\/j.ygyno.2020.11.003_bb0020","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"Walsh","year":"2011","journal-title":"PNAS"},{"issue":"8","key":"10.1016\/j.ygyno.2020.11.003_bb0025","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/jamaoncol.2018.0644","article-title":"Uptake, results, and outcomes of germline multiple-gene sequencing after diagnosis of breast cancer","volume":"4","author":"Kurian","year":"2018","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2020.11.003_bb0030","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","article-title":"Inherited mutations in women with ovarian carcinoma","volume":"2","author":"Norquist","year":"2016","journal-title":"JAMA Oncol."},{"issue":"14","key":"10.1016\/j.ygyno.2020.11.003_bb0035","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jama.2011.1456","article-title":"Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer","volume":"306","author":"Yang","year":"2011","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.ygyno.2020.11.003_bb0040","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10897-017-0135-2","article-title":"Cancer genetic counseling and testing: perspectives of epithelial ovarian cancer patients and gynecologic oncology healthcare providers","volume":"27","author":"Liang","year":"2018","journal-title":"J. Genet. Couns."},{"issue":"9737","key":"10.1016\/j.ygyno.2020.11.003_bb0045","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(10)60893-8","article-title":"Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial","volume":"376","author":"Audeh","year":"2010","journal-title":"Lancet."},{"issue":"4","key":"10.1016\/j.ygyno.2020.11.003_bb0050","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/jama.2012.20","article-title":"Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer","volume":"307","author":"Bolton","year":"2012","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ygyno.2020.11.003_bb0055","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1158\/1078-0432.CCR-13-2287","article-title":"Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas","volume":"20","author":"Pennington","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"19","key":"10.1016\/j.ygyno.2020.11.003_bb0060","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM199611073351901","article-title":"Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1","volume":"335","author":"Rubin","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2020.11.003_bb0065","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"issue":"9","key":"10.1016\/j.ygyno.2020.11.003_bb0070","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.ygyno.2020.11.003_bb0075","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1200\/JCO.2009.27.0835","article-title":"Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging","volume":"29","author":"Warner","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.11.003_bb0080","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/bjc.2012.204","article-title":"Long-term results of screening with magnetic resonance imaging in women with BRCA mutations","volume":"107","author":"Passaperuma","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2020.11.003_bb0085","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/AOG.0b013e3181da08d7","article-title":"Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities","volume":"115","author":"Meyer","year":"2010","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.11.003_bb0090","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/gim.2014.68","article-title":"Characteristics associated with genetic counseling referral and BRCA1\/2 testing among women in a large integrated health system","volume":"17","author":"Bellcross","year":"2015","journal-title":"Genet. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2020.11.003_bb0095","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ygyno.2013.05.003","article-title":"Keeping it simple: genetics referrals for all invasive serous ovarian cancers","volume":"130","author":"Demsky","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2020.11.003_bb0100","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.ajog.2016.02.011","article-title":"Underuse of BRCA testing in patients with breast and ovarian cancer","volume":"214","author":"Wright","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.ygyno.2020.11.003_bb0105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11864-016-0417-1","article-title":"Health care disparities in hereditary ovarian cancer: are we reaching the underserved population?","volume":"17","author":"Randall","year":"2016","journal-title":"Curr. Treat. Options in Oncol."},{"issue":"14","key":"10.1016\/j.ygyno.2020.11.003_bb0110","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.293.14.1729","article-title":"Racial differences in the use of BRCA1\/2 testing among women with a family history of breast or ovarian cancer","volume":"293","author":"Armstrong","year":"2005","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.ygyno.2020.11.003_bb0115","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1200\/JCO.18.01854","article-title":"Genetic testing and results in a population-based cohort of breast cancer patients and ovarian cancer patients","volume":"37","author":"Kurian","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"34","key":"10.1016\/j.ygyno.2020.11.003_bb0120","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1200\/JCO.2017.73.6314","article-title":"National estimates of genetic testing in women with a history of breast or ovarian cancer","volume":"35","author":"Childers","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2020.11.003_bb0125","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1200\/JCO.2017.76.2369","article-title":"Gaps in receipt of clinically indicated genetic counseling after diagnosis of breast cancer","volume":"36","author":"Katz","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2020.11.003_bb0130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ygyno.2017.05.037","article-title":"A universal genetic testing initiative for patients with high-grade, non-mucinous epithelial ovarian cancer and the implications for cancer treatment","volume":"146","author":"Bednar","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.11.003_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10549-017-4643-4","article-title":"Impact of an embedded genetic counselor on breast cancer treatment","volume":"169","author":"Pederson","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"issue":"5","key":"10.1016\/j.ygyno.2020.11.003_bb0140","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s10897-013-9598-y","article-title":"Genetic risk assessment for women with epithelial ovarian cancer: referral patterns and outcomes in a university gynecologic oncology clinic","volume":"22","author":"Petzel","year":"2013","journal-title":"J. Genet. Couns."},{"issue":"2","key":"10.1016\/j.ygyno.2020.11.003_bb0145","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ygyno.2017.08.030","article-title":"Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls","volume":"147","author":"Lilyquist","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.11.003_bb0150","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ygyno.2019.01.024","article-title":"Disparities in gynecologic cancer genetics evaluation","volume":"153","author":"Hinchcliff","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2020.11.003_bb0155","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/gim.2015.207","article-title":"Oncologists\u2019 and cancer patients\u2019 views on whole-exome sequencing and incidental findings: results from the CanSeq study","volume":"18","author":"Gray","year":"2016","journal-title":"Genet. Med."},{"issue":"13","key":"10.1016\/j.ygyno.2020.11.003_bb0160","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1200\/JCO.19.02010","article-title":"Cascading after peridiagnostic cancer genetic testing: an alternative to population-based screening","volume":"38","author":"Offit","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2020.11.003_bb0165","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/s41436-020-0797-2","article-title":"Positive impact of genetic counseling assistants on genetic counseling efficiency, patient volume, and cost in a cancer genetics clinic","volume":"22","author":"Hallquist","year":"2020","journal-title":"Genet. Med."},{"issue":"5","key":"10.1016\/j.ygyno.2020.11.003_bb0170","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/jgc4.1148","article-title":"The current state of genetic counseling assistants in the United States","volume":"28","author":"Hnatiuk","year":"2019","journal-title":"J. Genet. Couns."},{"issue":"4","key":"10.1016\/j.ygyno.2020.11.003_bb0175","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s10897-016-0039-6","article-title":"Genetic counseling assistants: an integral piece of the evolving genetic counseling service delivery model","volume":"26","author":"Pirzadeh-Miller","year":"2017","journal-title":"J. Genet. Couns."},{"issue":"15_suppl","key":"10.1016\/j.ygyno.2020.11.003_bb0180","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2020.38.15_suppl.1506","article-title":"Results from MAGENTA: A national randomized four-arm noninferiority trial evaluating pre- and post-test genetic counseling during online testing for breast and ovarian cancer genetic risk","volume":"38","author":"Swisher","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.11.003_bb0185","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ygyno.2016.07.094","article-title":"Video-assisted genetic counseling in patients with ovarian, fallopian and peritoneal carcinoma","volume":"143","author":"Watson","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2020.11.003_bb0190","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/jgc4.1169","article-title":"Patient assessment of chatbots for the scalable delivery of genetic counseling","volume":"28","author":"Schmidlen","year":"2019","journal-title":"J. Genet. Couns."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820341111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820341111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:57:18Z","timestamp":1758772638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825820341111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0090825820341111"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.11.003","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Embedding a genetic counselor into oncology clinics improves testing rates and timeliness for women with ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}